Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bryant M. Whiting"'
The History of Kidney Stone Dissolution Therapy: 50 Years of Optimism and Frustration With Renacidin
Publikováno v:
Journal of Endourology. 26:110-118
Over the last 50 years, chemolysis as a primary or adjuvant treatment for urinary stones has fallen in and out of favor. We review the literature for a historical perspective on the origins and chronology of Renacidin therapy, focusing on landmark st
Autor:
Bryant M. Whiting, Philip W. Lavori, John F. Carlquist, Matthew J. Kolek, Laura C. Lazzeroni, Surai Thaneemit-Chen, Benjamin D. Horne, Joseph B. Muhlestein, Jeffrey L. Anderson
Publikováno v:
Journal of Cardiac Failure. 11:677-683
A common variant of the adenosine monophosphate deaminase (AMPD)-1 gene (C34T) results in enzymatic inactivity and may increase adenosine in cardiac muscle and confer cardioprotection through ischemic preconditioning.We hypothesized that AMPD1 carrie
Autor:
Joseph B. Muhlestein, John F. Carlquist, Benjamin D. Horne, Bryant M. Whiting, Tami L Bair, Jeffrey L. Anderson, Robert R. Pearson
Publikováno v:
American Heart Journal. 150:243-250
Moderate-sized studies have suggested that variants of candidate genes can influence laboratory markers of coronary artery disease (CAD), but whether they predict parallel changes in clinical CAD risk is unknown.We studied a single nucleotide polymor
Publikováno v:
Journal of endourology. 25(10)
Calyceal diverticula are cystic dilations within renal parenchyma prone to urinary stasis, stone formation, and recurrent infection. Using ICD-9 code 55.39 and CPT code 50549, we identified five women and two men (mean age 42 years) who underwent lap
Autor:
Matthew J. Kolek, Donald L. Lappé, Jessica L. Clarke, Bryant M. Whiting, Brent C. James, John F. Carlquist, Jeffrey L. Anderson, Benjamin D. Horne, Joseph B. Muhlestein
Publikováno v:
Journal of thrombosis and thrombolysis. 22(3)
Warfarin has a narrow therapeutic range and wide inter-individual dosing requirements that may be related to functional variants of genes affecting warfarin metabolism (i.e., CYP2C9) and activity (i.e., vitamin K epoxide reductase complex subunit 1-V
Autor:
Bryant M. Whiting, Tami L Bair, John F. Carlquist, Joseph B. Muhlestein, Benjamin D. Horne, Matthew J. Kolek, Jeffrey L. Anderson
Publikováno v:
American heart journal. 148(6)
Background Coronary artery disease (CAD) and, increasingly, diabetes are recognized as having an inflammatory basis. Membrane toll-like receptors (TLRs) activate signaling pathways that up-regulate inflammation. We evaluated whether the Asp299Gly pol
Autor:
Bryant M. Whiting, John F. Carlquist, Jeffrey L. Anderson, Sandra P. Reyna, Benjamin D. Horne, Jason T. McKinney, Cory A. King, Kaisorn Chaichana, Joseph B. Muhlestein, Tami L Bair
Publikováno v:
Journal of the American College of Cardiology. 41(6)
Autor:
Jason M. Lappe, Robert R. Pearson, Johnny Walker, Jeffrey L. Anderson, John F. Carlquist, Benjamin D. Horne, Bryant M. Whiting, Matthew J. Kolek, Heath U. Jones, Joseph B. Muhlestein
Publikováno v:
Journal of the American College of Cardiology. 43(5):A297-A298
Autor:
Jill B. Faatz, Bryant M. Whiting, John F. Carquist, Benjamin D. Home, Cory A. King, Jeffrey L. Anderson, Joseph B. Muhlestein, Noal I. Hart, Henri O.F. Mulhuizen
Publikováno v:
Journal of the American College of Cardiology. 39:440-441
Autor:
Benjamin D. Horne, Joseph B. Muhlestein, Jeffrey L. Anderson, Bryant M. Whiting, Tami L Bair, Robert R. Pearson, John F. Carlquist
Publikováno v:
Journal of the American College of Cardiology. 41:249